Cargando…

Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity

BACKGROUND: Interleukin-35 (IL-35) has been reported to play an important role in the progression of cancers. The role of IL-35 in prostate cancer (PCA) is not well understood. In this study, we investigated the effects of IL-35 on PCA and its immunoregulatory effect on PCA. METHODS: The protein and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jialin, Wang, Yan, Li, Dai, Zhang, Haonan, Guo, Zhi, Yang, Xueling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541216/ https://www.ncbi.nlm.nih.gov/pubmed/33041668 http://dx.doi.org/10.1186/s12935-020-01583-3

Ejemplares similares

Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer
por: Zhu, Jialin, et al.
Publicado: (2019)

The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma
por: Xiao, Yi, et al.
Publicado: (2020)

RPL35A is a key promotor involved in the development and progression of gastric cancer
por: Wu, Fang, et al.
Publicado: (2021)

SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway
por: Liu, Zelin, et al.
Publicado: (2022)

LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1
por: Chen, Qi-Hua, et al.
Publicado: (2020)

miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
por: Zhang, Dapeng, et al.
Publicado: (2020)

Abiraterone and MDV3100 inhibits the proliferation and promotes the apoptosis of prostate cancer cells through mitophagy
por: Han, Jingli, et al.
Publicado: (2019)

DDX10 promotes the proliferation and metastasis of colorectal cancer cells via splicing RPL35
por: Zhou, Xin, et al.
Publicado: (2022)

LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway
por: Yu, Chuigong, et al.
Publicado: (2022)

Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer
por: Rong, Jiping, et al.
Publicado: (2020)

MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value
por: Wu, Xuejiao, et al.
Publicado: (2020)

ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments
por: Geng, Rong, et al.
Publicado: (2020)

LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathway
por: Meng, Liwei, et al.
Publicado: (2020)

PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in hepatocellular carcinoma
por: Liu, Fen, et al.
Publicado: (2013)

Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics
por: Zweiri, Jehad, et al.
Publicado: (2020)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates promising anti prostate cancer activity in vitro
por: Lowe, Henry I C, et al.
Publicado: (2012)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Promotion of tumor development in prostate cancer by progerin
por: Tang, Yong, et al.
Publicado: (2010)

TACR2 is associated with the immune microenvironment and inhibits migration and proliferation via the Wnt/β-catenin signaling pathway in prostate cancer
por: Jianfeng, Wang, et al.
Publicado: (2021)

Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression
por: Huang, Liping, et al.
Publicado: (2006)

Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM1
por: Dai, Yanping, et al.
Publicado: (2021)

Increased expression of Six1 correlates with progression and prognosis of prostate cancer
por: Zeng, Jun, et al.
Publicado: (2015)

Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
por: Yu, Chia-Cheng, et al.
Publicado: (2019)

Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration
por: Chen, Qingke, et al.
Publicado: (2021)

IFI35 is involved in the regulation of the radiosensitivity of colorectal cancer cells
por: Hu, Yan, et al.
Publicado: (2021)

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
por: Petővári, Gábor, et al.
Publicado: (2018)

Adenovirus-mediated anti-AEG-1 ScFv expression driven by stathmin promoter inhibits tumor growth in cervical cancer
por: Long, Min, et al.
Publicado: (2020)

miR-190 promotes malignant transformation and progression of human urothelial cells through CDKN1B/p27 inhibition
por: Huang, Shirui, et al.
Publicado: (2021)

Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer
por: Shi, Rong, et al.
Publicado: (2014)

The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer
por: Xiong, Kangping, et al.
Publicado: (2021)

Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p
por: Wu, Huijuan, et al.
Publicado: (2020)

Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
por: Xu, Peng, et al.
Publicado: (2022)

Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p
por: Chen, Fengling, et al.
Publicado: (2020)

Long non-coding RNA FER1L4 inhibits prostate cancer progression via sponging miR-92a-3p and upregulation of FBXW7
por: Huo, Wei, et al.
Publicado: (2020)

TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination
por: Chen, Jia-xin, et al.
Publicado: (2021)

Adipocytes promote tumor progression and induce PD-L1 expression via TNF-α/IL-6 signaling
por: Li, Zhi, et al.
Publicado: (2020)

Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer
por: Zhu, Xiaogang, et al.
Publicado: (2020)

MINDY1 promotes bladder cancer progression by stabilizing YAP
por: Luo, Yongwen, et al.
Publicado: (2021)

Postponing tumor onset and tumor progression can be achieved by alteration of local tumor immunity
por: Mei, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tj72tdqpjenmiiejcpuk2uq5lh